← TrialMatch
HomeTrials

Exercise and Nutrition for Healthy AgeiNg

The aim of this randomized placebo-controlled 5-arm clinical trial is to evaluate the effect of combined anabolic interventions compared to single or placebo interventions on physical performance in community-dwelling (pre)sarcopenic elderly (≥ 65 years) and to determine the underlying mechanisms of action. Important s

Condition(s)Sarcopenia
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe aim of this randomized placebo-controlled 5-arm clinical trial is to evaluate the effect of combined anabolic interventions compared to single or placebo interventions on physical performance in community-dwelling (pre)sarcopenic elderly (≥ 65 years) and to determine the underlying mechanisms of action. Important secondary outcome measures are muscle mass, muscle strength, compliance to the interventions (exercise program, protein and omega-3 supplementation) and functional, cognitive and nutritional status.
Who can participateInclusion Criteria: 1. Male or female persons with (pre)sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP): reduced muscle mass without (presarcopenia) or with (sarcopenia) reduced walking speed (≤ 0.8m/s) or muscle strength OR probable, confirmed or severe sarcopenia according to EWGSOP 2. 2. 65 years or older; 3. Community-dwelling elderly or assisted living; 4. In case of one or more positive answer(s) on the health screen for exercise, subjects need approval of their general practitioner to participate in this randomized controlled trial (RCT). * Uncontrolled or unstable health problems * Uncontrolled pain or feeling unwell the day of the exercise * Recently diagnosed cardiovascular events * systolic blood pressure (SBP) ≥ 180 mmHg and/or diastoli
Ages65 Years
SexAll
Lead sponsorUniversitaire Ziekenhuizen KU Leuven
LocationsLeuven, Vlaams-Brabant, Belgium
Start date2018-02-12
NCT IDNCT03649698
Official listinghttps://clinicaltrials.gov/study/NCT03649698

🔍 Search all trials →